Maria Buti, MD, PhD

Hospital Universitario Vall d’Hebron, Barcelona, Spain; CIBEREHD del Instituto Carlos III, Madrid, Spain, Spain

Disclosure(s): AbbVie: Speaker fees/research support/consulting fees; Gilead Sciences, Inc.: Speaker fees/research support/consulting fees; Janssen: Speaker fees/research support/consulting fees

Poster(s):

• (P-2195) Influence of Nucleos(t)ide Analogue Use with Bulevirtide on Treatment Outcomes in Chronic Hepatitis Delta
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET